Scotiabank Lowers Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target to $19.00
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) had its price objective lowered by stock analysts at Scotiabank from $51.00 to $19.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “sector outperform” rating on the biotechnology company’s stock. Several other brokerages also recently issued reports on RCKT. Canaccord Genuity […]
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) had its price objective lowered by stock analysts at Scotiabank from $51.00 to $19.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “sector outperform” rating on the biotechnology company’s stock. Several other brokerages also recently issued reports on RCKT. Canaccord Genuity […]
